obesity

Clinical trials show Wegovy triples the average weight loss seen with other drugs. Whether it will reach many patients largely depends on whether insurers decide to cover it.

Experts now say the procedure is the most effective treatment for severe childhood obesity, which affects a growing number of kids. But stigma and insurers often stand in the way.

At issue is a provision that requires physicians to have in-person consultations with patients before prescribing obesity-treatment drugs, which is inconsistent with the state’s telehealth law.

In company-funded studies, participants taking the Novo Nordisk drug Wegovy had average weight loss of about 34 pounds. In a comparison group getting dummy shots, the average loss was under 6 pounds.

Reporter Michael Moss says processed foods can be as alluring in some ways as cocaine or cigarettes. His new book explains how companies keep us snacking by appealing to nostalgia and brain chemistry.

As cities offer vaccine appointments for people with a BMI of at least 30 — the medical benchmark for obesity — Dr. Fatima Stanford pushes back against the shame faced by those with the disease.

For a world crippled by the coronavirus, salvation hinges on a vaccine.But in the United States, where at least 4.6 million people have been infected and…

A government study has found that 1 in 3 U.S. adults eat fast food on any given day. That's about 85 million people.It's the first federal study to look…

More than one in four Floridians is considered obese, according to the latest “State of Obesity: Better Policies for a Healthier America" report....

Who says doctors and insurers are at odds? The Florida Medical Association’s philanthropic arm has joined with its counterpart at Aetna to try to combat…